Trial Profile
Stratification of Biologic Therapies for RA by Pathobiology (STRAP): A randomised, open-labelled biopsy-driven stratification trial in DMARD inadequate responder patients randomised to Etanercept, Tocilizumab or Rituximab
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Dec 2021
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Etanercept; Tocilizumab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms STRAP
- 10 Jan 2021 Status changed from active, no longer recruiting to completed.
- 11 Dec 2020 Planned End Date changed from 21 Dec 2020 to 9 Jan 2021.
- 12 Dec 2018 Planned End Date changed from 16 Dec 2018 to 21 Dec 2020.